FoliuMed seals white label cannabis deals in South America

2y
1m read
Summary

About FoliuMed FoliuMed is a privately owned medical cannabis company founded in 2018 providing affordable, efficacious medical cannabis products “made in Germany, grown in Colombia“. FoliuMed, a medical cannabis company with manufacturing operations in Germany and cultivation in South America, recently concluded two major sales agreements with customers in Brazil and Colombia. Since its inception, it has exported to 8 countries and works as a contract manufacturer and white label producer for some of the leading cannabis players in Germany, Australia, the US and South America. SOURCE FoliuMed Under the terms of the deal, the customers commit to purchase 130,000 units of FoliuMed’s oral cannabinoid solutions with a binding take-or-pay clause for the first 35,000 units in 2022. “FoliuMed Product portfolio” The products are high dosage, full spectrum formulations derived from FoliuMed´s proprietary genetics, produced under Good Manufacturing Practice (GMP) and commercialized with the customers´ brands.

Article Preview

FoliuMed, a medical cannabis company with manufacturing operations in Germany and cultivation in South America, recently concluded two major sales agreements with customers in Brazil and Colombia. Under the terms of the deal, the customers commit to purchase 130,000 units of FoliuMed’s oral cannabinoid solutions with a binding take-or-pay clause for the first 35,000 units in 2022.

“FoliuMed Product portfolio”

The products are high dosage, full spectrum formulations derived from FoliuMed´s proprietary...

Read the full article @ Cannabis Law Report